SEPTIN9 and colorectal carcinoma: We further compared the five markers in 143 CRC cases from the prospective cohort who had enough plasma samples for simultaneous determination of methylated SEPTIN9 and the results showed that serum piR-54265 performed much better than methylated SEPTIN9 to distinguish the future CRC (Table S10).